Carmen Lorenz is researcher at Max Delbrueck Center for Molecular Medicine (MDC) in Berlin, Germany.
During Targeting Mitochondria World Congress, she will present her recent studies about "Probing MT-ATP6 mutations using iPSC-derived neural cells".
Volkmar Weissig and Marvin Edeas asked to Carmen Lorenz to highlight the following strategic points:
- Are iPSC-derrived neural cells a good model system for mitochondrial diseases?
- Can we find treatments for mitochondrial diseases?
- Can we detect a disease phenotype of mitochondrial neurological disorders in a dish?
Marvin Edeas stated: "Targeting Mitochondria and stem cells is one of the hot topics that we will largely discuss during Targeting Mitochondria 2016".
Marvin Edeas / Volkmar Weissig / Chairmen of WMS